СИНТЕЗ ПРОИЗВОДНЫХ ПИРИМИДИН-2,4(Ш,3Щ-ДИОНОВ, СОДЕРЖАЩИХ N-АЛКИЛЬНЫЕ ЗАМЕСТИТЕЛИRASKILDINA, G.Z.,
VALIEV, V.F.,
OZDEN, I.V.,
ZLOTSKII, S.S.,
MESHCHERYAKOVA, S.A.,
SPIRIKHIN, L.V.,
Раскильдина Г.З.,,
Валиев В.Ф.,,
Озден И.В.,,
Мещерякова С.А.,,
Спирихин Л.В.,,
Злотский С.С. (2017) mixture of
N1- and
N3-monosubstituted products, and the profound
N-alkylation of this compound provides
Zagidullin, N.S.,
Dunayeva, A.R.,
Plechev, V.V.,
Gilmanov, A.Z.,
Zagidullin, S.Z.,
Er, F.,
Pavlov, V.N. (2017) . The patients were randomized for RIPC (
n = 26, 60.5 ± 2.0 years) or
12 sRIPC (
n = 25, 62.96 ± 1.7). RIPC
randomized for RIPC (
n=26, 60.5±2.0 years) or sRIPC (
n=25, 62.96±1.7). RIPC was performed before the CAG